Max Bradley
Image of Max Bradley

Max Bradley

Specialized Practice Lawyer

Email

maxmilien.bradley@aoshearman.com

Phone

+1 212 848 4696

Offices

New York

V-CARD
Max focuses on the design, tax and securities law implications of compensation plans. He guides public and private company clients in structuring, rolling out, administering and winding up all types of compensation plans.
Max also handles compensation, benefits and employment matters arising in transactions and negotiates executive employment and separation agreements.

Max has an active pro bono practice, advising both individuals and non-profit organizations.

Max received his J.D. in 2018 from the University of Arizona, where he graduated first in his class and was a member of the Arizona Law Review and the Order of the Coif. He received his A.B. in 2011 from Princeton University.

Expertise

Experience

Representative matters

  • The Olayan Group in the administration of various employee and director compensation plans, and in its joint acquisition with Rock Mountain Capital, L.P. of a stake in specialty cleaning products manufacturer PurposeBuilt Brands, Inc.
  • City National Bank of Florida in the administration of various employee compensation plans.
  • Bluespring Wealth Partners in the administration of various employee compensation plans, and in its acquisitions of various independent investment advisors.
  • EPIC Brokers & Consultants in the administration of various employee compensation plans, and in its acquisitions of various insurance companies.
  • LVMH, Air Liquide, Sanofi, Capgemini, Valeo, Danone, Schneider Electric, Amundi, AXA, Saint-Gobain and other European corporations in the U.S. components of their global employee stock purchase plans.
  • The New York State Deferred Compensation Board in all legal issues arising in connection with the administration of the New York State Deferred Compensation Plan.
  • Advanced Disposal Services in its $4.9 billion acquisition by Waste Management.
  • A biomedical and biotechnology company in its acquisition of Baylis Medical Company for $1.75 billion.
  • A global chemical company in its spinoff from DowDuPont Inc., in various acquisitions, and in compensation-related securities law advice.
  • Various issuers and investors in connection with Section 13 and Section 16 beneficial ownership matters.
  • Various individual executives in connection with the negotiation of employment and severance agreements.

Qualifications

Admissions

Attorney-at-Law, New York, 2018

Academic

A.B., Princeton University, 2011

J.D., University of Arizona, 2018

Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.